34966 Federal Register / Vol. 71, No.
116 / Friday, June 16, 2006 / Notices
submitted to OMB within 30 days in
order to assure maximum consideration.
Department of the Interior practice is
to make comments, including names
and home addresses of respondents,
available for public review. Individual
respondents may request that we
withhold their home address from
public disclosure, which we will honor
to the extent allowable by law. There
also may be circumstances in which we
would withhold a respondent’s identity
from public disclosure, as allowable by
law. If you wish us to withhold your
name and/or address, you must state
this prominently at the beginning of
your comment. We will make all
submissions from organizations or
businesses, and from individuals
identifying themselves as
representatives or officials of
organizations or businesses, available
for public disclosure in their entirety.
Gerald W. Kelso,
Area Manager, Upper Columbia Area Office,
Pacific Northwest Region.
[FR Doc. E6–9452 Filed 6–15–06; 8:45 am]
BILLING CODE 4310–MN–P
DEPARTMENT OF THE INTERIOR
Bureau of Reclamation
Public Meeting for Reclamation’s
Managing for Excellence Project
AGENCY: Bureau of Reclamation,
Interior.
ACTION: Notice of Announcement of a
public meeting.
SUMMARY: The Bureau of Reclamation is
holding a meeting to inform the public
about the Managing for Excellence
project. This meeting is the first of three
meetings to inform the public about the
action items, progress, and results of the
Managing for Excellence project and to
seek broad feedback. Subsequent
meetings will likely be held in
September and November 2006 in other
metropolitan areas of the Western
United States.
DATES: July 10, 1 p.m.–5 p.m. and July
11, 2006, 8 a.m.–12 p.m.
ADDRESSES: Luxor Las Vegas, 3900 Las
Vegas Boulevard South, Las Vegas, NV
89119. General Session Room: Egyptian
ABC.
FOR FURTHER INFORMATION CONTACT:
Kerry Whitford (303) 445–2949.
SUPPLEMENTARY INFORMATION: The
wwhite on PROD1PC61 with NOTICES
Managing for Excellence Project will
identify and address the specific 21st
Century challenges Reclamation must
meet to fulfill its mission to manage,
develop, and protect water and related
VerDate Aug<31>2005 18:25 Jun 15, 2006 Jkt 208001
resources in an environmentally and
economically sound manner in the
interest of the American public. This
project will examine Reclamation’s core
capabilities and the agency’s ability to
respond to both expected and
unforeseeable future needs in an
innovative and timely manner. This
project will result in essential changes
in a number of key areas, which are
outlined in, Managing for Excellence—
An Action Plan for the 21st Century
Bureau of Reclamation. For more
information regarding the Project,
Action Plan, and specific actions being
taken, please visit the Managing for
Excellence Web page at http://
www.usbr.gov/excellence.
Registration
Although you may register the day of
the conference between 10 a.m. and 12
p.m., we highly encourage you to
register online at http://www.usbr.gov/
excellence, or by phone at 303–445–
2808.
Dated: June 7, 2006.
Trudy Harlow,
Acting Deputy Commissioner for External and
Intergovernmental Affairs, Washington
Office.
[FR Doc. 06–5461 Filed 6–15–06; 8:45 am]
BILLING CODE 4310–MN–M
INTERNATIONAL TRADE
COMMISSION
[Inv. No. 337–TA–539]
In the Matter of Certain Tadalafil or Any
Salt or Solvate Thereof and Products
Containing Same; Notice of
Commission Issuance of General
Exclusion Order; Decision To Grant
Motion To File a Surreply; Termination
of the Investigation
AGENCY: International Trade
Commission.
ACTION: Notice.
SUMMARY: Notice is hereby given that
the U.S. International Trade
Commission has found a violation of
section 337 of the Tariff Act of 1930, as
amended, 19 U.S.C. 1337, and has
issued a general exclusion order under
section 337(g)(2), 19 U.S.C. 1337(g)(2),
and terminated the investigation. The
Commission has decided to grant
complainant’s motion to file a surreply.
FOR FURTHER INFORMATION CONTACT: Jean
Jackson, Esq., Office of the General
Counsel, U.S. International Trade
Commission, 500 E Street, SW.,
Washington, DC 20436, telephone (202)
205–3104. Copies of non-confidential
documents filed in connection with this
PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 E:\FR\FM\16JNN1.SGM
investigation are or will be available for
inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the
Office of the Secretary, U.S.
International Trade Commission, 500 E
Street, SW., Washington, DC 20436,
telephone (202) 205–2000. General
information concerning the Commission
may also be obtained by accessing its
Internet server (http://www.usitc.gov).
The public record for this investigation
may be viewed on the Commission’s
electronic docket (EDIS) at http://
edis.usitc.gov. Hearing-impaired
persons are advised that information on
this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810.
SUPPLEMENTARY INFORMATION: This
investigation was instituted by the
Commission based on a complaint filed
by Lilly ICOS LLC (‘‘Lilly’’) of
Wilmington, Delaware, under section
337 of the Tariff Act of 1930, as
amended, 19 U.S.C. 1337. 70 FR 25601
(May 13, 2005). The complainant
alleged violations of section 337 in the
importation into the United States, the
sale for importation, and the sale within
the United States after importation of
certain tadalafil or any salt or solvate
thereof, and products containing same
by reason of infringement of claims 1–
4, 6–8, 12, and 13 of U.S. Patent No.
5,859,006 (‘‘the ‘006 patent’’). The
complaint and notice of investigation
named ten respondents.
On September 12, 2005, the
Commission issued a notice indicating
that it had determined not to review an
initial determination (‘‘ID’’) (Order No.
5) finding respondents Santovittorio
Holdings Ltd. d/b/a
Inhousepharmacy.co.uk of El Dorado,
Panama; Stop4Rx of Port-au-Prince,
Haiti, Rx Mex-Com, S.A. de C.V. of
Colonia Las Brisas, Mexico; and http://
www.Nudewfds.info of New Orleans,
Louisiana; in default. The ID further
found that respondent Express Generic
had not been properly served with the
complaint.
On November 17, 2005, the
Commission issued a notice that it had
determined not to review an ID (Order
No. 9) finding an additional five of the
originally named respondents in
default. The additional five respondents
are Budget Medicines Pty Ltd., of
Sydney, Australia; Generic Cialis
Pharmacy of Managua, Nicaragua;
Cutprice Pills of Scottsdale, Arizona;
Allpills.us of Beverly Hills, California;
and Pharmacy4u.us of New York, New
York.
On October 28, 2005, Lilly filed a
motion for summary determination on
the issues of the existence of a domestic
16JNN1